当期报告
Clearside Biomedical(CLSD)02-02 05:05
$Clearside生物医学(CLSD)$ 8-K Current report, item 1.01 Accession Number: 0000950170-24-009767 Act: 34 Size: 153 KB 网页链接
简介:Clearside Biomedical, Inc.是一个后期临床生物制药公司,开发先入类药物疗法来治疗眼睛的致盲疾病。公司目前的候选产品着力解决影响视网膜和脉络膜,尤其是黄斑水肿相关的疾病,并注入到使用其专有的SCS微量注射器脉络膜上腔。公司于2011年5月26日在特拉华州注册成立。
今开:1.27 | 昨收:1.26 |
最高:1.38 | 最低:1.27 |
涨停价: | 跌停价: |
总市值:100126326 |
Clearside Biomedical(CLSD)02-02 05:05
$Clearside生物医学(CLSD)$ 8-K Current report, item 1.01 Accession Number: 0000950170-24-009767 Act: 34 Size: 153 KB 网页链接
Clearside Biomedical(CLSD)03-13 04:25
$Clearside Biomedical(CLSD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-029956 Act: 34 Size: 314 KB 网页链接
Mr_晓风03-19 08:07
早上起来,睡前挂的单已成交,1.56买入1000股$Clearside Biomedical(CLSD)$ ,当彩票了。
Clearside Biomedical(CLSD)03-21 04:35
$Clearside Biomedical(CLSD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008752 Size: 4 KB 网页链接
Clearside Biomedical(CLSD)02-09 05:55
$Clearside生物医学(CLSD)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-028455 Act: 33 Size: 1 MB 网页链接
Clearside Biomedical(CLSD)02-09 06:15
$Clearside生物医学(CLSD)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001193125-24-028487 Act: 34 Size: 611 KB 网页链接
Clearside Biomedical(CLSD)03-13 05:25
$Clearside Biomedical(CLSD)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-030126 Act: 34 Size: 11 MB 网页链接
Clearside Biomedical(CLSD)02-10 02:05
$Clearside生物医学(CLSD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000933430-24-000001 Size: 7 KB 网页链接
Clearside Biomedical(CLSD)04-19 21:55
$Clearside Biomedical(CLSD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011199 Size: 6 KB 网页链接
Clearside Biomedical(CLSD)04-17 04:35
$Clearside Biomedical(CLSD)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-010868 Size: 10 KB 网页链接
Mr_晓风03-19 08:07
早上起来,睡前挂的单已成交,1.56买入1000股$Clearside Biomedical(CLSD)$ ,当彩票了。查看全文
美股滚雪球2023-11-06 10:15
$Biocryst医药(BCRX)$ 和$Clearside生物医学(CLSD)$ 宣布达成一项许可协议,开发一种更有效的方法来治疗糖尿病黄斑水肿(DME), DME是糖尿病患者最常见的致盲原因。
根据协议条款,BioCryst (BCRX)将使用Clearside (CLSD)的给药方法,即SCS Microinjector,通过脉络膜上间隙将其血浆钾化肽抑制...查看全文
韩信超短2022-03-11 22:38
$Clearside生物医学(CLSD)$ 快跑吧建仓期啊查看全文
韩信超短2022-03-11 22:32
$Clearside生物医学(CLSD)$ 看你会不会有作为查看全文
挟韭菜以令诸国2021-07-06 23:37
$Clearside生物医学(CLSD)$ 高潮就一瞬间查看全文
鲜克有终72021-06-15 19:42
chuminhua2021-06-03 10:21
Clearside Biomedical公司(纳斯达克股票代码:CLSD)XIPERE™(曲安奈德脉络膜上腔注射混悬液)用于治疗葡萄膜炎性黄斑水肿的新药上市申请再提交获得美国食品药品监督管理局受理。2020年3月,极目生物获得了XIPERE™ 在大中华区(中国大陆、中国香港、中国澳门、中国台湾)和韩国进行开发及商...查看全文
晓东152021-03-24 22:59
我与老公的日常2021-01-06 11:50
$Clearside生物医学(CLSD)$开弓没有回头箭查看全文
旭日待东升2020-01-07 11:06
下周即将召开JP morgan大会,这里提几只会上可以关注的标的。$Clearside生物医学(CLSD)$ 之前冲高过度回落,昨日宣布参加JP morgan大会股价上涨20%。$Five Prime(FPRX)$ 标的目前仍处于被低估的状态,也将参加JP morgan大会。同样值得关注的还有:SRPT(MDD明星药企,目前已经绝对领先),TGTX(3...查看全文
$Clearside Biomedical(CLSD)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-049248 Act: 34 Size: 1 MB 网页链接
$Clearside Biomedical(CLSD)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-118201 Act: 34 Size: 385 KB 网页链接
$Clearside Biomedical(CLSD)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-118177 Act: 34 Size: 1 MB 网页链接
$Clearside Biomedical(CLSD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011199 Size: 6 KB 网页链接
$Clearside Biomedical(CLSD)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-010868 Size: 10 KB 网页链接
$Clearside Biomedical(CLSD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010873 Size: 5 KB 网页链接
$Clearside Biomedical(CLSD)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0000950170-24-044594 Act: 34 Size: 323 KB 网页链接
$Clearside Biomedical(CLSD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008752 Size: 4 KB 网页链接
$Clearside Biomedical(CLSD)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-008297 Size: 10 KB 网页链接
$Clearside Biomedical(CLSD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008301 Size: 5 KB 网页链接